| 注册
首页|期刊导航|现代中医临床|清肝健脾法对桥本甲状腺炎患者TPOAb、TgAb滴度的影响

清肝健脾法对桥本甲状腺炎患者TPOAb、TgAb滴度的影响

杨泽佩 丁治国 张涛静 胡凯文 陈晓珩 李会龙 彰金 李哲

现代中医临床2025,Vol.32Issue(3):1-5,5.
现代中医临床2025,Vol.32Issue(3):1-5,5.DOI:10.3969/j.issn.2095-6606.2025.03.001

清肝健脾法对桥本甲状腺炎患者TPOAb、TgAb滴度的影响

Efficacy of liver-clearing and spleen-strengthening approach on TPOAb and TgAb titers in patients with Hashimoto's thyroiditis

杨泽佩 1丁治国 2张涛静 1胡凯文 1陈晓珩 3李会龙 3彰金 3李哲3

作者信息

  • 1. 北京中医药大学东方医院 北京 100078
  • 2. 北京中医药大学||北京中医药大学孙思邈医院甲状腺病院
  • 3. 北京中医药大学东直门医院
  • 折叠

摘要

Abstract

Objective To investigate the efficacy of the liver-clearing and spleen-strengthening approach on thyroid peroxidase antibody(TPOAb)and thyroglobulin antibody(TgAb)titers in patients with Hashimoto's thyroiditis(HT).Methods 1 649 outpatient patients from the Thyroid Department of Dongzhimen Hospital from June 2018 to September 2021 were selected and divided into low,medium,and high exposure groups based on the duration of herbal medicine administration.The effects of the three treatment groups on TPOAb and TgAb titers in HT patients were compared.Results In terms of the decrease in TPOAb titer,the median percentage of titer decrease in the low,medium,and high exposure groups of herbal medicine were 3.0%,8.0%,and 21.0%.In terms of the decrease of TgAb titer,the medians of the decrease percentage in the low,medium and high exposure groups were 1.0%,10.0%and 23.0%,The differences among the three groups were statistically significant(P<0.05).Conclusion The liver-clearing and spleen-strengthening approach can reduce the titer of TPOAb and TgAb in patients with HT.The longer time of taking herbal remedies(90-180 days)is more conducive to reducing antibody titers.

关键词

甲状腺过氧化物酶抗体/甲状腺球蛋白抗体/桥本甲状腺炎/清肝健脾法/中医药

Key words

thyroid peroxidase antibody/thyroglobulin antibody/Hashimoto's thyroiditis/clearing the liver and strengthening the spleen/Traditional Chinese Medicine

分类

医药卫生

引用本文复制引用

杨泽佩,丁治国,张涛静,胡凯文,陈晓珩,李会龙,彰金,李哲..清肝健脾法对桥本甲状腺炎患者TPOAb、TgAb滴度的影响[J].现代中医临床,2025,32(3):1-5,5.

基金项目

国家人口健康科学数据中心中西医结合防治甲状腺疾病专题数据库建设项目(No.NCMI202406B01) (No.NCMI202406B01)

陕西省中医药管理局中西医结合甲状腺病诊疗"双链融合"中青年科研创新团队项(No.2022-SLRH-LG-005) (No.2022-SLRH-LG-005)

陕西省卫生健康委员会陕西省卫生健康高层次人才(团队)培育计划项目-北京中医药大学孙思邈医院甲状腺疑难疾病中西医结合诊疗研发及应用创新团队(No.陕卫人函[2024]192号) (团队)

北京市中医管理局北京中医药"薪火传承3+3"工程(No.2016-32-C-61) (No.2016-32-C-61)

现代中医临床

2095-6606

访问量0
|
下载量0
段落导航相关论文